Rabin Medical Center: Diabetes Mellitus, Type 1 trials
The registry lists 40 Diabetes Mellitus, Type 1 studies with Rabin Medical Center as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 1Phase 3 1Phase 4 2No phase 33(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Assessing the Safety, Performance, and User Experience of the Tandem Mobi Automated Insulin Delivery System Among Young Competitive Athletes in Real-world Settings.Not yet recruitingNCT06979635Not applicable
- Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin InjectionsRecruitingNCT06966427Not applicable
- Carb Counting vs. Simplified Qualitative Meal-Size EstimationRecruitingNCT06687434Not applicable
- A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D PatientsRecruitingNCT06665815
- The Effect of Omega Galil Hazelnut Chocolate Spread "O'Sweet Spread" With 80% Reduced Sucrose on Glucose Response of People With TIDRecruitingNCT06334302Not applicable
- The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes PatientsRecruitingNCT05788341
- Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes MellitusRecruitingNCT04834518
- Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1TerminatedNCT05610722Not applicable
- Use of Insulin Adjustment Device DreaMed Advisor Pro During Routine Clinical Use for Subjects With Diabetes Type 1CompletedNCT04271228Not applicable
- An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 DiabetesCompletedNCT04269668Not applicable
- Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept StudyTerminatedNCT04014569Not applicable
- The Advisor Pro Direct StudyTerminatedNCT03774069Not applicable
- Personalized Automated Determination of Insulin Pump Setting for Subjects With Type 1 Diabetes Switching From MDI to Pump Therapy and Vice Versa- Safety and Efficacy Feasibility StudyCompletedNCT03574558Not applicable
- Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro StudyCompletedNCT03003806Not applicable
- Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2CompletedNCT02776696Not applicable
- Patients Perceptions of Using the "Libre" System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat TrialCompletedNCT02776007Not applicable
- Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 DiabetesWithdrawnNCT02733211Not applicable
- Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes The DREAMED TrailCompletedNCT02651181Not applicable
- Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments StudyTerminatedNCT02617160Not applicable
- Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense as a Tool for Detection of HypoglycemiaCompletedNCT02225379Not applicable
- The Effects of Mediterranean Diet on Remission, Lipid Profile, Weight and Body Composition in Children and Adolescents With Newly Diagnosed Type 1 DiabetesTerminatedNCT02131896Not applicable
- MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals ManagementCompletedNCT01901913Not applicable
- Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's HomeCompletedNCT01726829Not applicable
- MICHAEL Method- Fulfilling Individual Potential to Attain Excellence - as a Tool for Improving Metabolic Control and Quality of Life Among Adolescence With Type 1 DiabetesCompletedNCT01691287Not applicable
- Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 DiabetesCompletedNCT01661192Phase 2
- Accu-Chek Combo in Young PatientsCompletedNCT01657630
- The Effect of the Use of Computer Game- "My Diabetic Friend" in Children With Type 1 DiabetesCompletedNCT01600664Not applicable
- Non Invasive Breath Based Acetone-meter- Easy CheckTerminatedNCT01530347Phase 1
- MDRS for Prevention of Nocturnal HypoglycemiaCompletedNCT01509157Phase 1
- Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 DiabetesWithdrawnNCT01501032Phase 1
- OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277TerminatedNCT01460251Phase 3
- MD Logic Pump Advisor -Pediatric StudyCompletedNCT01308164Not applicable
- Assessing Continuous Non- Invasive Blood Glucose Sensor- Physical Logic AGTerminatedNCT01247649Not applicable
- Overnight MD-LogicCompletedNCT01238406Not applicable
- MD Logic Pump Advisor- Adults StudyCompletedNCT01157923Not applicable
- Treatment Satisfaction of Using OmniPod System Compared With Conventional Insulin Pump in Adults With Type 1 DiabetesCompletedNCT00935129Not applicable
- Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and AdolescentsTerminatedNCT00925977Not applicable
- The Effects of Regular Home Use Vs Diabetic Team- Supported Use of the Medtronic CareLink Therapy Management System.CompletedNCT00814476Phase 4
- Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir InjectionsCompletedNCT00542399Phase 4
- The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.Status unknownNCT00491465Not applicable